+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Cardiac Monitoring Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4591656
  • Report
  • June 2020
  • Region: Europe
  • 80 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotelemetry
  • Biotronik
  • GE Healthcare
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • MORE
The key factors propelling the growth of the market is the growing incidences of cardiovascular diseases, advancements in the technology and the demand for home-based, point of care, and remote monitoring cardiac systems during the forecast period.

Coronary heart disease (CHD) is found to be the most common type of heart disease. According to the British Heart Foundation Centre in 2018, there are around 7.4 million people living with heart and circulatory diseases in the United Kingdom. More than 43,000 people under the age of 75 in the United Kingdom die from heart and circulatory diseases each year.

There is also an increase in the prevalence of obesity among adults and youth that is one of the leading cause for cardiovascular diseases, which in turn boosts the market growth. Thus as the incidence of cardiovascular diseases is increasing, the awareness of people about health is increasing, thus prompting people to search for easier and accessible diagnostics or treatment methods, such as cardiac monitoring devices, which are easy to use. Hence the market is expected to witness high growth due to the increase in cardiovascular diseases, over the forecast period.

Key Market Trends

ECG Monitor Segment is Expected to Dominate the Cardiac Monitoring Market During the Forecast Period

Cardiovascular disease (CVD) incidence has increased in many Europpean countries over thee years. FOr instance, as per a 2018 report by the National Health Service of the United Kingdom, the incidence of CVD increased from 1.64 million in 2010-11 to approximately 1.73 million in 2017-18.

As there is an increase in the incidence of cardiovascular diseases (CVD), long-term ECG monitoring is being required. Usually, this procedure is possible in hospitals. However, with the introduction of wireless ECG, the doctors can monitor and diagnose the patient remotely and on time. There are two different types of ECG monitors available in the market namely the monitoring ECG systems and diagnostic ECG systems.

The development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of the ECG monitors segment, globally. Furthermore, technological advancements and product innovations taking place in the development of ECG devices are likely to propel the market growth.

Competitive Landscape

The Europe cardiac monitoring market is exceptionally fragmented and focused because of the presence of many large, medium, and small players. The multinational players possess a substantial share of the worldwide market. The companies in the cardiac monitoring market are focusing on various growth strategies, like M&A, partnerships, collaborations, geographical expansions, and new product launches to enhance their market presence.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotelemetry
  • Biotronik
  • GE Healthcare
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidences of Cardiovascular Diseases
4.2.2 Advancements in the Technology
4.2.3 Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems
4.3 Market Restraints
4.3.1 Risk of Infection due to Implantable Monitoring Devices
4.3.2 Unfavorable Reimbursement Policies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 ECG Monitor
5.1.2 Event Recorder
5.1.3 Implantable Loop Recorder
5.1.4 Pacemaker
5.1.5 Defibrillator
5.1.6 Cardiac Resynchronization Therapy (CRT) Devices
5.1.7 Smart Wearable Devices
5.1.8 Other Device Types
5.2 By End User
5.2.1 Hospitals and Clinics
5.2.2 Home Care Settings
5.2.3 Ambulatory Surgical Centers
5.3 Geography
5.3.1 Europe
5.3.1.1 Germany
5.3.1.2 United Kingdom
5.3.1.3 France
5.3.1.4 Italy
5.3.1.5 Spain
5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Medtronic Plc
6.1.3 Boston Scientific Corporation
6.1.4 GE Healthcare
6.1.5 Koninklijke Philips N.V.
6.1.6 Biotronik
6.1.7 Hill-Rom Holdings
6.1.8 Schiller
6.1.9 Biotelemetry

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Biotronik
  • Hill-Rom Holdings
  • Schiller
  • Biotelemetry
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll